I
Iosif Kelesidis
Researcher at Albert Einstein College of Medicine
Publications - 33
Citations - 2765
Iosif Kelesidis is an academic researcher from Albert Einstein College of Medicine. The author has contributed to research in topics: Heart failure & Ejection fraction. The author has an hindex of 17, co-authored 33 publications receiving 2494 citations. Previous affiliations of Iosif Kelesidis include Beth Israel Deaconess Medical Center & University of Pennsylvania.
Papers
More filters
Journal ArticleDOI
Narrative Review: The Role of Leptin in Human Physiology: Emerging Clinical Applications
TL;DR: Replacement of leptin in physiologic doses restores ovulatory menstruation in women with hypothalamic amenorrhea and improves metabolic dysfunction in patients with lipoatrophy, including lipoat rophy associated with HIV or highly active antiretroviral therapy.
Journal ArticleDOI
Adiponectin and cancer: a systematic review
TL;DR: Recent findings on the association of adiponectin with several malignancies as well as recent data on underlying molecular mechanisms that provide novel insights into the association between obesity and cancer risk are presented.
Journal ArticleDOI
Detection of left atrial appendage thrombus by cardiac computed tomography in patients with atrial fibrillation: a meta-analysis.
TL;DR: Cardiac computed tomography, particularly when delayed imaging is performed, is a reliable alternative to TEE for the detection of LA/LAA thrombi/clot, avoiding the discomfort and risks associated with TEE.
Journal ArticleDOI
Total and High-Molecular-Weight Adiponectin in Breast Cancer: In Vitro and in Vivo Studies
Antje Körner,Kalliopi Pazaitou-Panayiotou,Theodoros Kelesidis,Iosif Kelesidis,Catherine J. Williams,Athina Kaprara,John W. Bullen,Anke K Neuwirth,Sofia Tseleni,Nicholas Mitsiades,Wieland Kiess,Christos S. Mantzoros +11 more
TL;DR: It is suggested that adiponectin may act as a biomarker of carcinogenesis and may constitute a molecular link between obesity and breast cancer.
Journal ArticleDOI
Tigecycline for the treatment of multidrug-resistant (including carbapenem-resistant) Acinetobacter infections: a review of the scientific evidence
Drosos E. Karageorgopoulos,Theodore Kelesidis,Theodore Kelesidis,Iosif Kelesidis,Iosif Kelesidis,Matthew E. Falagas,Matthew E. Falagas +6 more
TL;DR: Tigecycline showed considerable, though not consistent, antimicrobial activity against MDR (including carbapenem-resistant) Acinetobacter spp.